Ionizable Cationic Lipids for Nuclease-Resistant Targeted mRNA Delivery
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
The delivery of mRNA to immune cells, such as macrophages, monocytes, and dendritic cells, is challenging due to nuclease degradation and low cell permeability, necessitating improved methods for efficient and targeted delivery to ensure robust protein expression.
Innovation Solution
Development of ionizable cationic lipids and lipid nanoparticle compositions that protect mRNA from serum nucleases, specifically target immune cells, and deliver the payload to the cytosolic compartment for translation, utilizing a combination of ionizable cationic lipids, immune cell targeting groups, and lipid nanoparticle formulations.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional delivery vehicles are used, then mRNA can be delivered to cells, but the mRNA is degraded by nucleases and cell permeability is low
Solution Approach 1:
The patent uses ionizable cationic lipids as intermediary carriers that protect mRNA from nuclease degradation. These lipids form lipoplexes with mRNA, shielding it from nucleases in the extracellular environment and facilitating cellular uptake without direct contact between the mRNA and harmful nucleases.
Solution Approach 2:
The invention employs composite lipid formulations combining ionizable cationic lipids with neutral lipids and PEGylated lipids. This composite approach creates nanoparticles with enhanced stability, reduced nuclease degradation, and improved cellular permeability, addressing multiple limitations of conventional delivery vehicles simultaneously.
2Productivity
If mRNA delivery is enhanced, then protein expression increases, but off-target effects increase
Solution Approach 1:
The patent incorporates immune cell-specific targeting moieties (such as antibodies or ligands) on the surface of the lipid nanoparticles. This localizes the delivery to specific immune cell types (macrophages, dendritic cells, or B cells), ensuring high protein expression in the target population while minimizing off-target effects in non-target cells.
3Measurement precision
If targeting specificity is improved, then off-target effects are reduced, but delivery efficiency may decrease
Solution Approach 1:
The ionizable cationic lipid nanoparticle platform is designed to be multi-functional: it protects mRNA from degradation, facilitates cellular uptake, enables specific targeting through conjugated moieties, and ensures efficient delivery to the cytosol. This universal platform approach maintains high delivery efficiency while accommodating various targeting specificities through modular conjugation of different targeting moieties.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The solution enhances mRNA delivery to immune cells, achieving higher protein expression levels and specificity, with reduced off-target effects and improved stability, thereby facilitating effective therapeutic interventions.
Implementation Method 1
The nanoparticles are intended to protect the RNA from degradation
Implementation Method 2
the delivery of therapeutic RNAs to cells is difficult in view of the relative instability and low cell permeability of RNAs
Implementation Method 3
specifically target immune cells, and deliver the payload to the cytosolic compartment
Data Source
AI summary
Provided are ionizable cationic lipids and lipid nanoparticles for the delivery of nucleic acids to cells (e.g., immune cells), and methods of making and using such lipids and targeted lipid nanoparticles.